Exodus Point Capital Management, LP Pacira Bio Sciences, Inc. Transaction History

Exodus Point Capital Management, LP

  • $9.1 Billion
  • Q3 2025

A detailed history of Exodus Point Capital Management, LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 58,290 shares of PCRX stock, worth $1.39 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
58,290
Holding current value
$1.39 Million
% of portfolio
0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$21.09 - $27.22 $1.23 Million - $1.59 Million
58,290 New
58,290 $1.5 Million
Q1 2025

May 14, 2025
BUY
$18.33 - $27.25 $1.3 Million - $1.94 Million
71,158 Added 33.44%
283,982 $7.06 Million
Q4 2024

Feb 12, 2025
BUY
$15.3 - $20.33 $2.28 Million - $3.03 Million
148,842 Added 232.63%
212,824 $4.01 Million
Q3 2024

Nov 12, 2024
BUY
$11.7 - $28.46 $748,589 - $1.82 Million
63,982 New
63,982 $963,000
Q1 2024

May 14, 2024
BUY
$27.7 - $35.48 $330,627 - $423,489
11,936 Added 81.16%
26,643 $779,000
Q3 2023

Nov 09, 2023
SELL
$30.68 - $40.09 $273,297 - $357,121
-8,908 Reduced 37.72%
14,707 $451,000
Q2 2023

Aug 10, 2023
BUY
$36.12 - $47.5 $3,539 - $4,655
98 Added 0.42%
23,615 $946,000
Q1 2023

May 11, 2023
SELL
$35.53 - $43.38 $1.14 Million - $1.39 Million
-32,097 Reduced 57.71%
23,517 $960,000
Q4 2022

Feb 13, 2023
BUY
$38.19 - $57.45 $2.12 Million - $3.2 Million
55,614 New
55,614 $2.15 Million
Q3 2022

Nov 10, 2022
SELL
$51.24 - $58.89 $874,615 - $1.01 Million
-17,069 Closed
0 $0
Q2 2022

Aug 19, 2022
BUY
$51.49 - $81.64 $878,882 - $1.39 Million
17,069 New
17,069 $995,000
Q4 2020

Feb 16, 2021
SELL
$50.47 - $66.26 $614,371 - $806,582
-12,173 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$51.97 - $63.0 $632,630 - $766,899
12,173 New
12,173 $732,000
Q1 2020

May 15, 2020
SELL
$28.4 - $50.7 $697,702 - $1.25 Million
-24,567 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$36.31 - $46.83 $39,723 - $51,232
1,094 Added 4.66%
24,567 $1.11 Million
Q3 2019

Nov 14, 2019
SELL
$35.66 - $44.99 $873,135 - $1.1 Million
-24,485 Reduced 51.06%
23,473 $894,000
Q2 2019

Aug 14, 2019
BUY
$36.57 - $47.97 $1.75 Million - $2.3 Million
47,958 New
47,958 $2.09 Million
Q1 2019

May 15, 2019
SELL
$36.47 - $42.17 $283,955 - $328,335
-7,786 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$41.31 - $52.16 $321,639 - $406,117
7,786 New
7,786 $335,000

Others Institutions Holding PCRX

# of Institutions
261
Shares Held
48.9M
Call Options Held
118K
Put Options Held
63.7K
View Full List

About Pacira BioSciences, Inc.

PCRX Quotes by TradingView
  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.09B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email